Cencora Inc.
COR | NYSE
$339.68
-$14.32 (-4.05%)
At close: Nov 5, 2026, 4:00 PM ET
$339.68
$0.00 (0.00%)
After-hours:
Nov 5, 2026, 5:30 PM ET
Company Profile
Cencora, Inc. functions as a global leader in the sourcing and distribution of pharmaceutical products, with operations spanning both the United States and international markets. Within its U.S. Healthcare Solutions segment, the company supplies a broad spectrum of pharmaceutical items, including generic and injectable medications, over-the-counter health products, and home healthcare equipment. Its extensive client network includes acute care hospitals, health systems, a variety of retail and mail-order pharmacies (independent, chain, long-term care), medical clinics, and other healthcare providers. This division also manages the distribution of crucial specialized pharmaceutical products like plasma, blood derivatives, and vaccines. Beyond product supply, Cencora offers comprehensive support services, such as pharmacy management, staffing solutions, and strategic consulting. It develops and implements supply management software, provides packaging services for both institutional and retail healthcare settings, and assists with clinical trial support, post-market approval processes, and commercialization strategies. For biotechnology and pharmaceutical manufacturers, the company delivers data analytics, outcomes research, and other specialized services. Furthermore, Cencora serves the animal health market, providing pharmaceuticals, vaccines, parasiticides, diagnostics, and micro feed ingredients for both companion and production animals. It also offers sales force support to manufacturers and specialized services to medical professionals, particularly oncologists, as well as to hospitals and dialysis clinics. The International Healthcare Solutions division concentrates on global pharmaceutical wholesale activities, associated services, and worldwide commercialization support. It ensures the efficient distribution of medicines, various healthcare goods, and related services to an international customer base comprising pharmacies, doctors, health centers, and hospitals. This segment also delivers specialized transportation and logistics solutions specifically designed for the biopharmaceutical sector. Founded in 1871, the company was formerly known as AmerisourceBergen Corporation before adopting the name Cencora, Inc. in August 2023. Its corporate headquarters are situated in Conshohocken, Pennsylvania.
Key Executives
| Name | Position |
|---|---|
| Robert Mauch | President, Chief Executive Officer & Director |
| Elizabeth S. Campbell | Executive Vice President & Chief Legal Officer |
| Eva C. Boratto | Executive Vice President & Chief Financial Officer |
| Bennett S. Murphy | Senior VP Of Investor Relations & Enterprise Productivity and Treasury |
| James F. Cleary Jr. | Advisor |
| Lazarus Krikorian | Senior Vice President, Chief Accounting Officer & Corporate Controller |
| Pawan Singh Verma | Executive Vice President and Chief Data & Information Officer |
| Richard Tremonte | EVP and President of U.S. Pharmaceuticals & Animal Health |
| Samantha L. Hammock | Executive Vice President & Chief Human Resources Officer |
| Silvana Battaglia | Advisor |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 01, 2026 | 3 | Filing |
| Sep 25, 2026 | 8-K | Current Report |
| Sep 17, 2026 | 4 | Filing |
| Sep 02, 2026 | 4 | Filing |
| Aug 25, 2026 | 4 | Filing |
| Aug 14, 2026 | 8-K | Current Report |
| Aug 12, 2026 | 8-K | Current Report |
| Aug 05, 2026 | 10-Q | Quarterly Report |
| Aug 05, 2026 | 8-K | Current Report |
| Aug 05, 2026 | 8-K | Current Report |
Cencora Inc.
| Country | United States |
| IPO Date | Apr 4, 1995 |
| Industry | Medical - Distribution |
| Sector | Healthcare |
| Employees | 49,000 |
| CEO | Robert Mauch |
Contact Details
1 West First Avenue Conshohocken,
Pennsylvania 19428-1800 United States
Stock Details
| Ticker Symbol | COR |
| Exchange | NYSE |
| Fiscal Year | October - September |
| Reporting Currency | USD |
| CIK Code | 0001140859 |
| CUSIP Number | 03073E105 |
| ISIN Number | US03073E1055 |
| SIC Code | 5122 |
Recent News
- 22 hours ago / marketbeat.comWhat Cencora (COR) Said on Its Q4 Earnings Call
- 1 day ago / zacks.comCencora Q4 Earnings & Revenues Beat on Specialty Growth, Margins Expand
- 1 day ago / seekingalpha.comCencora, Inc. (COR) Q4 2026 Earnings Call Transcript
- 1 day ago / zacks.comCencora (COR) Reports Q4 Earnings: What Key Metrics Have to Say
- 1 day ago / zacks.comCencora (COR) Surpasses Q4 Earnings and Revenue Estimates
- 1 day ago / businesswire.comCencora Announces New Organizational and Reporting Structure to Enhance Visibility and Focus
- 1 day ago / businesswire.comCencora Reports Fiscal 2026 Fourth Quarter and Fiscal Year End Results
- 2 days ago / zacks.comWhy Cencora (COR) is a Top Growth Stock for the Long-Term
- 6 days ago / zacks.comCencora Gears Up to Report Q4 Results: How to Play the Stock?
- 6 days ago / zacks.comUnveiling Cencora (COR) Q4 Outlook: Wall Street Estimates for Key Metrics
Add to Watchlist
Select watchlists to add or remove COR